# OXACILLIN

NDC: 0338-1015
Generic name: OXACILLIN
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 19891026

FDA application: NDA050640

## Active ingredients

- OXACILLIN SODIUM: 2 g/50mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0338-1015"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0338-1015
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d893e45b-7f18-4c67-b10c-1e2e52a6b3ef